Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 1:16 PM
Ignite Modification Date:
2025-12-26 @ 1:16 PM
NCT ID:
NCT00216606
Eligibility Criteria:
Inclusion Criteria:
* History of migraine for \>= 1 year
* Headache type meets HIS (International Headache Society) criteria for migraine
* History reflects "chronic" headache--an average of \>= 15 migraine days per month in the 3 months preceding trial entry
* History of chronic migraine for \>=1 year\>=15 headaches per month with an average duration of 4 hours if not treated
* Patient is otherwise neurologically and physically healthy on a pre-trial exam.
Exclusion Criteria:
* Any other type of chronic headache (besides migraine) from section 2 to 13 of the International Headache Society classification or headache resulting directly resulting some other factor (except for medication overuse)
* Onset of migraine after age 50
* Use of an anticonvulsant drug in the month prior to trial entry
* Use of an antidepressant unless dose has been used at a stable dose for \>=3 months
* Use of migraine prevention medicine in the 3 months prior to trial entry unless the drug has been used for at least 3 months and used at a stable dose for at least a month
* Use of a carbonic anhydrase inhibitor such as acetazolamide (used to treat high blood pressure, glaucoma and seizures) or triamterene (a "water pill" for swelling and high blood pressure).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00216606
Study Brief:
Protocol Section:
NCT00216606